Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2006-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2008-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2008534649-A |
titleOfInvention |
Antitumor combination comprising a substituted acryloyl distamycin derivative and an antibody that inhibits a growth factor or receptor thereof |
abstract |
The present invention inhibits acryloyl distamycin derivatives (especially the α-bromo- and α-chloro-acryloyl distamycin derivatives of formula (I) described herein) and growth factors or receptors thereof in the treatment of tumors. Provide combined use of antibodies. Also provided is the use of the combination in the treatment or prevention of metastasis or the treatment of tumors by inhibiting angiogenesis. |
priorityDate |
2005-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |